3 minute read

Life Science and Section 101: USPTO New Examiner Guidelines

Kevin E. Noonan, Ph.D.May 25, 20162:00 pm - 3:00 pmWebinar

MBHB Partner Dr. Kevin Noonan Is a Featured Presenter at this IPO-Sponsored Webinar

MBHB Partner Dr. Kevin Noonan is a featured presenter at this Intellectual Property Owners Association (“IPO”) sponsored webinar set for 2:00-3:00 p.m. ET on May 25, 2016.

Life Science and Section 101: USPTO New Examiner Guidelines

A senior lawyer at the USPTO and two experienced life science patent prosecutors will use this webinar to probe deeply into the new examples published this month that show how claims for life science inventions should be examined by the agency for subject-matter patent eligibility. They will look in detail at the first four examples, two centering on diagnostics and two on inventions that involve a product of nature. Attendees will benefit most if they are already familiar with the examples and have a printed copy of the examples available to refer to during the webinar. The examples are available on the USPTO website. The panelists will crystallize the examples into “dos and don’t” for patent prosecutors in life science matters relating to Subject 101. They will also discuss pending litigation and how the guidelines will have to change if the U.S. Supreme Court denies certiorari in the Sequenom case. The two diagnostic examples do not apply the 2015 Federal Circuit decision in Sequenom.

View details here